Clinics ()

Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

  • Luis Eduardo Miani Gomes,
  • Francesca Aparecida Ramos da Silva,
  • Lívia Bitencourt Pascoal,
  • Renato Lazarin Ricci,
  • Guilherme Nogueira,
  • Michel Gardere Camargo,
  • Maria de Lourdes Setsuko Ayrizono,
  • João José Fagundes,
  • Raquel Franco Leal

DOI
https://doi.org/10.6061/clinics/2019/e1517
Journal volume & issue
Vol. 74

Abstract

Read online

No abstracts available.